69 related articles for article (PubMed ID: 23875665)
1. FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
Wessman S; Fuentes BB; Severin-Karlsson J; Westbom-Fremer S; Nistér M; Kokaraki G; Petta TB; Haglund F; Carlson JW
Int J Gynecol Pathol; 2024 Jan; 43(1):78-89. PubMed ID: 37255476
[TBL] [Abstract][Full Text] [Related]
2. [Genetic characteristics of ovarian malignant germ cell tumors].
Sun XJ; Liu CR
Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):641-646. PubMed ID: 38825917
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiles in non‑epithelial ovarian tumors.
Chang RK; Li X; Mu N; Hrydziuszko O; Garcia-Majano B; Larsson C; Lui WO
Int J Oncol; 2018 Jan; 52(1):55-66. PubMed ID: 29138809
[TBL] [Abstract][Full Text] [Related]
4. Recently characterized molecular events in uncommon gynaecological neoplasms and their clinical importance.
Witkowski L; McCluggage WG; Foulkes WD
Histopathology; 2016 Dec; 69(6):903-913. PubMed ID: 27504996
[TBL] [Abstract][Full Text] [Related]
5. Adult-type granulosa cell tumor of the ovary.
Li X; Tian B; Liu M; Miao C; Wang D
Am J Cancer Res; 2022; 12(8):3495-3511. PubMed ID: 36119817
[TBL] [Abstract][Full Text] [Related]
6. International trends in ovarian cancer incidence from 1973 to 2012.
Hao W; Zhang Y; Li Z; Zhang E; Gao S; Yin C; Yue W
Arch Gynecol Obstet; 2021 Jun; 303(6):1589-1597. PubMed ID: 33616706
[TBL] [Abstract][Full Text] [Related]
7. Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review.
Maoz A; Matsuo K; Ciccone MA; Matsuzaki S; Klar M; Roman LD; Sood AK; Gershenson DM
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32485873
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer statistics, 2018.
Torre LA; Trabert B; DeSantis CE; Miller KD; Samimi G; Runowicz CD; Gaudet MM; Jemal A; Siegel RL
CA Cancer J Clin; 2018 Jul; 68(4):284-296. PubMed ID: 29809280
[TBL] [Abstract][Full Text] [Related]
9. The molecular mechanism of ovarian granulosa cell tumors.
Li J; Bao R; Peng S; Zhang C
J Ovarian Res; 2018 Feb; 11(1):13. PubMed ID: 29409506
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathologic features of patients with non-epithelial ovarian cancer: retrospective analysis of a single institution 15-year experience.
Kempf E; Desamericq G; Vieites B; Diaz-Padilla I; Calvo E; Estevez P; Garcia-Arreza A; Martinez-Maestre MA; Duran I
Clin Transl Oncol; 2017 Feb; 19(2):173-179. PubMed ID: 27193130
[TBL] [Abstract][Full Text] [Related]
11. FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas.
Raman P; Purwin T; Pestell R; Tozeren A
Cancer Inform; 2015; 14():113-9. PubMed ID: 26494976
[TBL] [Abstract][Full Text] [Related]
12. Intrauterine factors and risk of nonepithelial ovarian cancers.
Sieh W; Sundquist K; Sundquist J; Winkleby MA; Crump C
Gynecol Oncol; 2014 May; 133(2):293-7. PubMed ID: 24530563
[TBL] [Abstract][Full Text] [Related]
13. Genetic changes in nonepithelial ovarian cancer.
Van Nieuwenhuysen E; Lambrechts S; Lambrechts D; Leunen K; Amant F; Vergote I
Expert Rev Anticancer Ther; 2013 Jul; 13(7):871-82. PubMed ID: 23875665
[TBL] [Abstract][Full Text] [Related]
14. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
[TBL] [Abstract][Full Text] [Related]
15. Mutation of FOXL2 in granulosa-cell tumors of the ovary.
Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG
N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027
[TBL] [Abstract][Full Text] [Related]
16. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on testicular sex cord-stromal tumors and those composed of both germ cells and sex cord-stromal derivatives with a comparison to corresponding ovarian neoplasms.
Roth LM; Lyu B; Cheng L
Hum Pathol; 2017 Jul; 65():1-14. PubMed ID: 28445692
[TBL] [Abstract][Full Text] [Related]
18. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
Young RH
Mod Pathol; 2005 Feb; 18 Suppl 2():S81-98. PubMed ID: 15502809
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
